Search Results


  1. Ceftriaxone: A Beta-lactamase—stable, Broad-spectrum Cephalosporin with an Extended Half-life

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 5, Issue 5, September-October 1985, Pages: 237–253, Thomas R. Beam Jr.

    Article first published online : 24 JAN 2012, DOI: 10.1002/j.1875-9114.1985.tb03423.x

  2. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia (CME)


    Volume 52, Issue 3, March 2012, Pages: 602–612, Patricia A. Arndt, Regina M. Leger and George Garratty

    Article first published online : 31 AUG 2011, DOI: 10.1111/j.1537-2995.2011.03321.x

  3. In vitro assessment of the formation of ceftriaxone–calcium precipitates in human plasma

    Journal of Pharmaceutical Sciences

    Volume 100, Issue 6, June 2011, Pages: 2300–2310, Hans-Rudolf Schmutz, Pascal Detampel, Theo Bühler, André Büttler, Benjamin Gygax and Jörg Huwyler

    Article first published online : 19 JAN 2011, DOI: 10.1002/jps.22466

  4. You have free access to this content
    Intratracheal co-administration of antioxidants and ceftriaxone reduces pulmonary injury and mortality rate in an experimental model of sepsis


    Volume 19, Issue 7, October 2014, Pages: 1080–1087, Andre M. Galvão, Marcela S.O. Wanderley, Roberto A. Silva, Carlos A.M. Filho, Mário R. Melo-Junior, Luciano A. Silva, Emílio L. Streck, Armele F. Dornelas de Andrade, Maria B. Souza Maia and Celia M.M. Barbosa de Castro

    Article first published online : 14 AUG 2014, DOI: 10.1111/resp.12363

  5. Systemic pharmacokinetics and cerebrospinal fluid uptake of intravenous ceftriaxone in patients with amyotrophic lateral sclerosis

    The Journal of Clinical Pharmacology

    Volume 54, Issue 10, October 2014, Pages: 1180–1187, Yanli Zhao, Merit E. Cudkowicz, Jeremy M. Shefner§, Lisa Krivickas, William S. David, Francine Vriesendorp, Alan Pestronk, James B. Caress, Jonathan Katz, Ericka Simpson, Jeffrey Rosenfeld, Robert Pascuzzi, Jonathan Glass, Kourosh Rezania, Jerold S. Harmatz, David Schoenfeld and David J. Greenblatt

    Article first published online : 16 MAY 2014, DOI: 10.1002/jcph.317

    Corrected by:

    Erratum: Erratum

    Vol. 54, Issue 11, 1320, Article first published online: 18 OCT 2014

  6. Pharmacokinetics of ceftriaxone in plasma and bone of patients undergoing hip or knee surgery

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 11, November 2014, Pages: 1552–1558, Ulrich Gergs, Tobias Clauss, Dorothea Ihlefeld, Michael Weiss, Klaus Pönicke, Gunther O. Hofmann and Joachim Neumann

    Article first published online : 19 JUN 2014, DOI: 10.1111/jphp.12282

  7. You have free access to this content
    The beta-lactam antibiotic, ceftriaxone, attenuates morphine-evoked hyperthermia in rats

    British Journal of Pharmacology

    Volume 151, Issue 7, August 2007, Pages: 1095–1102, S M Rawls, R Tallarida, W Robinson and M Amin

    Article first published online : 17 FEB 2009, DOI: 10.1038/sj.bjp.0707309

  8. You have free access to this content
    Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal

    British Journal of Clinical Pharmacology

    Volume 72, Issue 5, November 2011, Pages: 758–767, Denis Garot, Renaud Respaud, Philippe Lanotte, Nicolas Simon, Emmanuelle Mercier, Stephan Ehrmann, Dominique Perrotin, Pierre-François Dequin and Chantal Le Guellec

    Article first published online : 11 OCT 2011, DOI: 10.1111/j.1365-2125.2011.04005.x

  9. The in vitro antibacterial activity of ceftriaxone against Streptococcus pyogenes is unrelated to penicillin-binding protein 4

    FEMS Microbiology Letters

    Volume 110, Issue 3, July 1993, Pages: 313–317, Sizhuang Yan, Paul M. Mendelman and Dennis L. Stevens

    Article first published online : 17 JAN 2006, DOI: 10.1111/j.1574-6968.1993.tb06341.x

  10. Upregulation of GLT-1 by treatment with ceftriaxone alleviates radicular pain by reducing spinal astrocyte activation and neuronal hyperexcitability

    Journal of Neuroscience Research

    Volume 92, Issue 1, January 2014, Pages: 116–129, K.J. Nicholson, T.M. Gilliland and B.A. Winkelstein

    Article first published online : 3 OCT 2013, DOI: 10.1002/jnr.23295

  11. Biliary Sludge and Hyperbilirubinemia Associated with Ceftriaxone in an Adult: Case Report and Review of the Literature

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 10, October 2005, Pages: 1389–1395, Courtney L. Bickford and Anne P. Spencer

    Article first published online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.10.1389

  12. Indications for a ceftriaxone dosing regimen in Japanese paediatric patients using population pharmacokinetic/pharmacodynamic analysis and simulation

    Journal of Pharmacy and Pharmacology

    Volume 63, Issue 1, January 2011, Pages: 65–72, Satofumi Iida, Takehiko Kawanishi and Masahiro Hayashi

    Article first published online : 14 DEC 2010, DOI: 10.1111/j.2042-7158.2010.01179.x

  13. Adverse events induced by ceftriaxone: a 10-year review of reported cases to Iranian Pharmacovigilance Centre

    Journal of Clinical Pharmacy and Therapeutics

    Volume 37, Issue 4, August 2012, Pages: 448–451, G. Shalviri, S. Yousefian and K. Gholami

    Article first published online : 28 NOV 2011, DOI: 10.1111/j.1365-2710.2011.01321.x

  14. Ceftriaxone attenuates acute cocaine-evoked dopaminergic neurotransmission in the nucleus accumbens of the rat

    British Journal of Pharmacology

    Volume 172, Issue 22, November 2015, Pages: 5414–5424, J L Barr, B A Rasmussen, C S Tallarida, J L Scholl, G L Forster, E M Unterwald and S M Rawls

    Article first published online : 22 OCT 2015, DOI: 10.1111/bph.13330

  15. Cationic analog of deoxycholate as an oral delivery carrier for ceftriaxone

    Journal of Pharmaceutical Sciences

    Volume 94, Issue 11, November 2005, Pages: 2541–2548, Seulki Lee, Sang Kyoon Kim, Dong Yun Lee, Kyeongsoon Park, Tadiparthi Suresh Kumar, Su Young Chae and Youngro Byun

    Article first published online : 30 SEP 2005, DOI: 10.1002/jps.20478

  16. You have free access to this content
    13th European Congress of Clinical Microbiology and Infectious Diseases

    Clinical Microbiology and Infection

    Volume 9, Issue s1, May 2003, Pages: 1–422,

    Article first published online : 8 MAY 2003, DOI: 10.1046/j.1469-0691.9.s1.83.x

  17. Lack of Probenecid Effect on Nonrenal Excretion of Ceftriaxone in Anephric Patients

    The Journal of Clinical Pharmacology

    Volume 30, Issue 5, May 1990, Pages: 449–453, Dr. Indravadan H. Patel, Mr. Peter P. Soni, Mr. John J. Carbone, Dr. Patricia R. Audet, Dr. Gail Morrison and Dr. Gene A. Gibson

    Article first published online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1990.tb03484.x

  18. You have free access to this content
    Clinical and bacteriological outcomes in hospitalised patients with community-acquired pneumonia treated with azithromycin plus ceftriaxone, or ceftriaxone plus clarithromycin or erythromycin: a prospective, randomised, multicentre study

    Clinical Microbiology and Infection

    Volume 13, Issue 2, February 2007, Pages: 162–171, M. Tamm, T. Todisco, C. Feldman, J. Garbino, F. Blasi, P. Hogan, P. J. De Caprariis and I. M. Hoepelman

    Article first published online : 29 NOV 2006, DOI: 10.1111/j.1469-0691.2006.01633.x

  19. Interindividual variability in biliary excretion of ceftriaxone: effects on biliary lipid metabolism and on intestinal microflora

    European Journal of Clinical Investigation

    Volume 18, Issue 3, June 1988, Pages: 261–266, ANNIE ARVIDSSON, BARBRO LEIJD, C. E. NORD and B. ANGELIN

    Article first published online : 20 MAR 2008, DOI: 10.1111/j.1365-2362.1988.tb01256.x

  20. Factors influencing ceftriaxone use in community-acquired pneumonia: Emergency doctors’ perspectives

    Emergency Medicine Australasia

    Volume 26, Issue 6, December 2014, Pages: 591–595, Maher Ali Almatar, Gregory M Peterson, Angus Thompson and Syed Tabish R Zaidi

    Article first published online : 10 NOV 2014, DOI: 10.1111/1742-6723.12326